From Financial Modeling Prep: 2025-05-05 12:54:00

Zimmer Biomet (NYSE:ZBH) exceeded first-quarter expectations with adjusted earnings of $1.81 per share and revenue of $1.91 billion, driven by a 3.7% rise in U.S. hip sales. However, shares fell over 9% on lowered full-year guidance of $7.90 to $8.10 per share, citing the impact of acquiring Paragon 28 and currency challenges.



Read more at Financial Modeling Prep:: Zimmer Biomet Beats Q1 Expectations, But Stock Dro…